Category: US31447E1055

ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s…